Optinose, inc. (OPTN)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Operating activities:
Net loss

-110,035

-110,053

-111,439

-107,755

-104,960

-106,658

-99,828

-87,773

-71,399

-48,902

0

0

0

Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization

1,148

1,108

1,091

958

651

539

388

273

291

166

0

0

0

Stock-based compensation

9,898

9,860

9,770

9,537

8,942

8,543

9,621

8,190

6,397

5,096

0

0

0

Amortization of debt discount and issuance costs

813

658

495

458

444

404

295

184

77

198

0

0

0

Loss on sale of equipment

-

-

-

-

-

-

-

-

-

-

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

5,940

11,333

7,822

5,640

3,744

2,310

2,923

3,671

2,049

0

0

0

0

Grants and other receivables

50

-68

50

79

-147

196

-42

-7

29

-337

0

0

0

Prepaid expenses and other assets

-1,741

26

603

-1,193

1,986

762

535

394

-648

-2,358

0

0

0

Inventory

-115

-3,759

-2,741

-828

1,736

4,698

6,458

4,736

3,556

2,013

0

0

0

Accounts payable

-2,309

-3,856

-1,323

-3,999

32

3,171

3,532

4,992

6,532

392

0

0

0

Accrued expenses and other liabilities

8,375

11,845

7,082

2,593

3,697

10,150

10,441

13,389

11,940

6,688

0

0

0

Cash used in operating activities

-89,089

-90,815

-92,903

-101,906

-98,513

-91,817

-85,425

-69,539

-51,148

-35,680

0

0

0

Investing activities:
Purchases of property and equipment

459

557

725

1,232

1,476

1,690

2,646

2,576

2,698

2,406

0

0

0

Cash used in investing activities

-459

-557

-725

-1,232

-1,476

-1,690

-2,646

-2,576

-2,698

-2,406

0

0

0

Financing activities:
Proceeds from long-term debt

0

-

-

-

0

-

-

-

-

-

-

-

-

Cash paid for financing costs

6,398

5,776

3,360

198

4,724

6,547

19,116

19,504

15,071

13,433

0

0

0

Proceeds from the sale of common stock

-

-

-

-

-

-

-

-

-

36,712

0

0

0

Proceeds from long-term debt

-

-

-

-

-

0

0

0

0

-

-

-

-

Proceeds from issuance of common stock under employee stock purchase plan

2,231

2,404

-127

612

173

0

0

0

0

-

-

-

-

Proceeds from the exercise of stock options

1,023

1,038

612

1,000

1,373

1,488

1,552

991

264

134

0

0

0

Cash provided by financing activities

66,719

37,529

-2,385

2,083

61,460

59,579

260,074

258,168

199,617

236,125

0

0

0

Effects of exchange rate changes on cash and cash equivalents

-2

-3

0

0

0

-

-

-

-

-

-

-

-

Effects of exchange rate changes on cash and cash equivalents

-

-

-

-

-

-

-

-

-12

-11

0

0

0

Net decrease in cash, cash equivalents and restricted cash

-22,831

-53,846

-96,001

-101,025

-38,470

-33,864

0

0

0

-

0

0

0

Supplemental disclosure of noncash activities:
Deemed dividend

-

-

-

-

-

-

-

-

-

-

0

0

0

Accretion to redemption value

-

-

-

-

-

-

-

-

-

-

0

0

0

Fixed asset purchases within accounts payable and accrued expenses

555

483

-155

-198

-157

0

172

233

303

0

0

0

0

Recognition of initial lease liabilities

-

-

-

-

-

0

1,032

1,135

3,125

2,454

0

0

0

Recognition of right-of-use assets

0

-

0

0

0

-

0

0

0

-

-

-

-

Recognition of lease liabilities

0

-

0

0

0

-

0

0

0

-

-

-

-

Conversion of convertible notes payable and accrued interest into Series C-2 preferred stock

-

-

-

-

-

-

-

-

-

237,259

0

0

0